Skip to main content
. 2022 Oct 20;10:1044791. doi: 10.3389/fped.2022.1044791

Table 1.

Perioperative characteristics stratified by RAEs during transport.

Variablesa RAEs (n = 67) No-RAEs (n = 223) P value
Age, years 3.2 ± 2.3 3.8 ± 2.3 0.091
Age >3 years 26 (38.8) 121 (54.3) 0.027*
Sex     0.464
 Male 24 (35.8) 91 (40.8)  
 Female 43 (64.2) 132 (59.2)  
ASA grade     0.907
 II 57 (85.1) 191 (85.7)  
 III 10 (14.9) 32 (14.3)  
Height, cm 94.6 ± 17.6 101.2 ± 17.7 0.026*
Weight, kg 14.8 ± 6.1 16.5 ± 7.4 0.080
BMI, kg/m2 16.0 ± 1.8 15.8 ± 2.0 0.596
History of allergy 14 (20.9) 30 (13.5) 0.136
History of asthma 1 (1.5) 3 (1.3) >0.999
History of hay fever 5 (7.5) 22 (9.9) 0.553
Bronchial hyperreactivity 2 (3.0) 4 (1.8) 0.625
Osas 24 (35.8) 70 (31.4) 0.497
Passive smoking 23 (34.3) 65 (29.1) 0.419
Type of surgery     0.006*
 VSD 16 (23.9) 93 (41.7)  
 ASD 22 (32.8) 74 (33.2)  
 PDA 29 (43.3) 56 (25.1)  
Preoperative URI 41 (61.2) 92 (41.3) 0.004*
Propofol, mg 56.3 ± 26.5 61.1 ± 25.8 0.194
Morphine equivalent, mg 0.18 ± 0.04 0.17 ± 0.04 0.189
Morphine equivalent >0.153 mg/kg 53 (79.1) 147 (65.0) 0.041*
Muscle relaxant 1 (1.5) 5 (2.2) >0.999
Atropine usage 28 (41.8) 139 (62.3) 0.003*
Dexmedetomidine 49 (73.1) 139 (62.3) 0.104
Operative time, min 36.9 ± 18.2 36.8 ± 20.3 0.969
Anesthesia time, min 41.5 ± 18.4 41.8 ± 20.0 0.921
Extubation time, min 3.5 ± 2.7 3.5 ± 2.9 0.891
Deep extubation 61 (91.0) 196 (87.9) 0.476
Emergence agitation 5 (7.5) 25 (11.2) 0.377
Vomiting 3 (4.5) 16 (7.2) 0.579
Fever 1 (1.5) 5 (2.2) >0.999
RAEs during extubation to transport 41 (61.2) 58 (26.0) <0.001*

RAEs, respiratory adverse events; ASA, American society of anesthesiology; BMI, body mass index; VSD, ventricular septal defects; ASD, atrial septal defects; PDA, patent ductus arteriosus; URI, upper respiratory tract infection.

a

Continuous data are shown as mean ± standard deviation and categoric data as number (%).

*

Statistically significant (P < 0.05).